News

ANVISA has published, on 08/02/2017, in the Federal Register, the the Public Consultation 371/2017 to discuss the extension, from 5 to 10 … Medical Devices – ANVISA´s Public Consultation to extend the registration term

The Ministry of Industry and Commerce (MDIC) and the Brazilian Patent and Trademark Office (INPI) have opened for Public Consultation a Proposal for a Resolution to regulate a simplified allowance procedure for patent applications in Brazil, aiming to deal in a swift manner with the ever increasing backlog of patent applications awaiting examination, currently exceeding the figure of 230.000.

The Ministry of Industry and Commerce (MDIC) and the Brazilian Patent and Trademark Office (INPI) have opened for Public Consultation a Proposal for a Resolution to regulate a simplified allowance procedure for patent applications in Brazil, aiming to deal in a swift manner with the ever increasing backlog of patent applications awaiting examination, currently exceeding the figure of 230.000.

Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial … São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending

ANVISA has informed in its website, on 07/04/2017, the undertake of an operation that determined the shutdown, for at least 30 days, of a manufacturing line of personalized face and skull prostheses.
According to ANVISA, the Senai Joinville (a branch of the National Industrial Apprentice Service) has been manufacturing customized prostheses without authorization of the regulatory agency.

The article gives a high-level overview of data protection rules and principles, including obligations on the data controller and the consent of data subjects, rights to access personal data or object to its collection, security requirements, among other data issues.  

Advertising and Marketing seeks to provide local answers to international questions concerning advertising and marketing law. Chapters provide expert advice on the legislation and regulation of advertising and marketing, including the legislative processes arising from advertising disputes and challenges, the regulation of misleading advertising and the control, prohibition and restrictions in place on certain type of goods and services and to certain audiences, regulations affecting direct and indirect marketing and promotion, and up-to-date analysis of social media and the latest advertising trends.

Three major developments in Brazil suggest the country is entering an exciting era for IP owners. Gabriel Francisco Leonardos and Pedro Vilhena of Kasznar Leonardos report.

During the last BIO International Convention, Anderson Ribeiro, Partner at Kasznar Leonardos, spoke to bioBr Magazine about the recent regulatory framework for the Brazilian Pharmaceutical sector.

This article originally appeared on bioBR Magazine.

In a decision published on March 3, 2017, the 4th Chamber of the Brazilian Superior Court of Justice provided the criteria to decide cases in which identical marks are registered by different owners as domain names and trademarks (Recurso Especial nº. 1466212).

This is the sixth edition of the IAM Patent 1000 – The World's Leading Patent Professionals, a guide that identifies leading firms and patent professionals around the world. Kasznar Leonardos is once again ranked in the gold category of the guide, positioning itself among the market leaders.

With the aim of expanding the office's operations and reinforcing its growth strategy, we announce the arrival of the lawyer Fernanda Magalhães, who will lead an important area for the development of KL: Marketing & Entertainment Law.

Kasznar Leonardos was featured in the ranking Innovation – Technology and Intellectual Property 2017, released by the Leaders League. The firm was classified in 8 categories, having 11 partners mentioned in the publication. 

April 12, 2017 was an unusual day for the Brazilian Intellectual Property System. The Brazilian Patent Office (BPO) announced 3 good news for IP owners.

Further to our newsletter 12/16, please be informed that the Brazilian Patent Office issued on 1.March 2017 the Resolution No. 179 revoking Resolution 174, which was addressed in said previous newsletter.